UniProt ID | RBP1_HUMAN | |
---|---|---|
UniProt AC | Q15311 | |
Protein Name | RalA-binding protein 1 | |
Gene Name | RALBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 655 | |
Subcellular Localization |
Membrane Peripheral membrane protein . |
|
Protein Description | Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. Serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDK1 to switch off endocytosis, One of its substrates would be EPN1/Epsin.. | |
Protein Sequence | MTECFLPPTSSPSEHRRVEHGSGLTRTPSSEEISPTKFPGLYRTGEPSPPHDILHEPPDVVSDDEKDHGKKKGKFKKKEKRTEGYAAFQEDSSGDEAESPSKMKRSKGIHVFKKPSFSKKKEKDFKIKEKPKEEKHKEEKHKEEKHKEKKSKDLTAADVVKQWKEKKKKKKPIQEPEVPQIDVPNLKPIFGIPLADAVERTMMYDGIRLPAVFRECIDYVEKYGMKCEGIYRVSGIKSKVDELKAAYDREESTNLEDYEPNTVASLLKQYLRDLPENLLTKELMPRFEEACGRTTETEKVQEFQRLLKELPECNYLLISWLIVHMDHVIAKELETKMNIQNISIVLSPTVQISNRVLYVFFTHVQELFGNVVLKQVMKPLRWSNMATMPTLPETQAGIKEEIRRQEFLLNCLHRDLQGGIKDLSKEERLWEVQRILTALKRKLREAKRQECETKIAQEIASLSKEDVSKEEMNENEEVINILLAQENEILTEQEELLAMEQFLRRQIASEKEEIERLRAEIAEIQSRQQHGRSETEEYSSESESESEDEEELQIILEDLQRQNEELEIKNNHLNQAIHEEREAIIELRVQLRLLQMQRAKAEQQAQEDEEPEWRGGAVQPPRDGVLEPKAAKEQPKAGKEPAKPSPSRDRKETSI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTECFLPPT ------CCCCCCCCC | 41.27 | 28464451 | |
2 | Acetylation | ------MTECFLPPT ------CCCCCCCCC | 41.27 | 19413330 | |
9 | Phosphorylation | TECFLPPTSSPSEHR CCCCCCCCCCCCCCC | 39.64 | 23401153 | |
10 | Phosphorylation | ECFLPPTSSPSEHRR CCCCCCCCCCCCCCC | 46.13 | 29255136 | |
11 | Phosphorylation | CFLPPTSSPSEHRRV CCCCCCCCCCCCCCC | 34.62 | 23401153 | |
13 | Phosphorylation | LPPTSSPSEHRRVEH CCCCCCCCCCCCCCC | 48.24 | 29255136 | |
22 | Phosphorylation | HRRVEHGSGLTRTPS CCCCCCCCCCCCCCC | 32.32 | 23898821 | |
25 | Phosphorylation | VEHGSGLTRTPSSEE CCCCCCCCCCCCCCC | 35.70 | 23898821 | |
27 | Phosphorylation | HGSGLTRTPSSEEIS CCCCCCCCCCCCCCC | 23.45 | 29255136 | |
29 | Phosphorylation | SGLTRTPSSEEISPT CCCCCCCCCCCCCCC | 50.17 | 29255136 | |
30 | Phosphorylation | GLTRTPSSEEISPTK CCCCCCCCCCCCCCC | 40.21 | 29255136 | |
34 | Phosphorylation | TPSSEEISPTKFPGL CCCCCCCCCCCCCCC | 29.78 | 25159151 | |
36 | Phosphorylation | SSEEISPTKFPGLYR CCCCCCCCCCCCCCC | 38.23 | 30278072 | |
42 | Phosphorylation | PTKFPGLYRTGEPSP CCCCCCCCCCCCCCC | 16.43 | 23403867 | |
44 | Phosphorylation | KFPGLYRTGEPSPPH CCCCCCCCCCCCCCC | 32.13 | 30266825 | |
48 | Phosphorylation | LYRTGEPSPPHDILH CCCCCCCCCCCCCCC | 46.92 | 25159151 | |
62 | Phosphorylation | HEPPDVVSDDEKDHG CCCCCCCCCCCCCCC | 38.91 | 29255136 | |
82 | Phosphorylation | FKKKEKRTEGYAAFQ CCCCCCCCCCCCCCC | 44.84 | 23927012 | |
85 | Phosphorylation | KEKRTEGYAAFQEDS CCCCCCCCCCCCCCC | 6.63 | 23927012 | |
92 | Phosphorylation | YAAFQEDSSGDEAES CCCCCCCCCCCCCCC | 35.15 | 23927012 | |
93 | Phosphorylation | AAFQEDSSGDEAESP CCCCCCCCCCCCCCH | 63.69 | 25159151 | |
99 | Phosphorylation | SSGDEAESPSKMKRS CCCCCCCCHHHCCCC | 41.33 | 23927012 | |
101 | Phosphorylation | GDEAESPSKMKRSKG CCCCCCHHHCCCCCC | 55.45 | 23927012 | |
106 | Phosphorylation | SPSKMKRSKGIHVFK CHHHCCCCCCEEEEC | 29.71 | 23312004 | |
116 | Phosphorylation | IHVFKKPSFSKKKEK EEEECCCCCCCHHHH | 51.54 | 21955146 | |
118 | Phosphorylation | VFKKPSFSKKKEKDF EECCCCCCCHHHHCC | 48.15 | 21955146 | |
147 | Ubiquitination | KHKEEKHKEKKSKDL HHHHHHHHHHHHHCC | 80.46 | 22817900 | |
149 | Ubiquitination | KEEKHKEKKSKDLTA HHHHHHHHHHHCCCH | 68.12 | 22817900 | |
150 | Ubiquitination | EEKHKEKKSKDLTAA HHHHHHHHHHCCCHH | 64.92 | 22817900 | |
151 | Phosphorylation | EKHKEKKSKDLTAAD HHHHHHHHHCCCHHH | 42.33 | 23312004 | |
152 | Ubiquitination | KHKEKKSKDLTAADV HHHHHHHHCCCHHHH | 66.68 | 21906983 | |
161 | Ubiquitination | LTAADVVKQWKEKKK CCHHHHHHHHHHHHC | 50.73 | 23000965 | |
164 | Ubiquitination | ADVVKQWKEKKKKKK HHHHHHHHHHHCCCC | 58.10 | 23000965 | |
166 | Ubiquitination | VVKQWKEKKKKKKPI HHHHHHHHHCCCCCC | 67.19 | 23000965 | |
167 | Ubiquitination | VKQWKEKKKKKKPIQ HHHHHHHHCCCCCCC | 71.55 | 23000965 | |
201 | Phosphorylation | LADAVERTMMYDGIR HHHHHHHHHHCCCCC | 7.87 | 29978859 | |
204 | Phosphorylation | AVERTMMYDGIRLPA HHHHHHHCCCCCCCH | 10.53 | 27642862 | |
219 | Phosphorylation | VFRECIDYVEKYGMK HHHHHHHHHHHHCCC | 7.21 | - | |
234 | Phosphorylation | CEGIYRVSGIKSKVD CCEEEEECCHHHHHH | 26.29 | 24719451 | |
244 | Ubiquitination | KSKVDELKAAYDREE HHHHHHHHHHHCCCC | 28.99 | 29967540 | |
252 | Phosphorylation | AAYDREESTNLEDYE HHHCCCCCCCHHHCC | 20.17 | 22817900 | |
253 | Phosphorylation | AYDREESTNLEDYEP HHCCCCCCCHHHCCH | 47.29 | 22817900 | |
258 | Phosphorylation | ESTNLEDYEPNTVAS CCCCHHHCCHHHHHH | 24.74 | 27642862 | |
265 | Phosphorylation | YEPNTVASLLKQYLR CCHHHHHHHHHHHHH | 29.87 | 24719451 | |
268 | Ubiquitination | NTVASLLKQYLRDLP HHHHHHHHHHHHHCC | 42.04 | 29967540 | |
270 | Phosphorylation | VASLLKQYLRDLPEN HHHHHHHHHHHCCHH | 11.34 | 19413330 | |
280 | Phosphorylation | DLPENLLTKELMPRF HCCHHHCCHHHHHHH | 26.16 | 19413330 | |
281 | Ubiquitination | LPENLLTKELMPRFE CCHHHCCHHHHHHHH | 49.14 | 24816145 | |
297 | Phosphorylation | ACGRTTETEKVQEFQ HHCCCCCHHHHHHHH | 38.73 | 22817900 | |
299 | Ubiquitination | GRTTETEKVQEFQRL CCCCCHHHHHHHHHH | 57.55 | 29967540 | |
353 | Phosphorylation | LSPTVQISNRVLYVF ECCEEEECCCHHHHH | 11.07 | 22817900 | |
421 | Ubiquitination | RDLQGGIKDLSKEER HHHCCCCCCCCHHHH | 56.76 | 24816145 | |
454 | Ubiquitination | KRQECETKIAQEIAS HHHHHHHHHHHHHHH | 17.47 | - | |
461 | Phosphorylation | KIAQEIASLSKEDVS HHHHHHHHCCHHHCC | 38.55 | 30266825 | |
463 | Phosphorylation | AQEIASLSKEDVSKE HHHHHHCCHHHCCHH | 31.35 | 19664994 | |
468 | Phosphorylation | SLSKEDVSKEEMNEN HCCHHHCCHHHHCCC | 46.82 | 25850435 | |
469 | Ubiquitination | LSKEDVSKEEMNENE CCHHHCCHHHHCCCH | 58.50 | - | |
509 | Phosphorylation | FLRRQIASEKEEIER HHHHHHHCCHHHHHH | 51.32 | 22817900 | |
511 | Ubiquitination | RRQIASEKEEIERLR HHHHHCCHHHHHHHH | 59.14 | 24816145 | |
600 | Ubiquitination | LLQMQRAKAEQQAQE HHHHHHHHHHHHHHH | 55.43 | 29967540 | |
632 | Ubiquitination | VLEPKAAKEQPKAGK CCCHHHHHCCCCCCC | 62.84 | 24816145 | |
645 | Phosphorylation | GKEPAKPSPSRDRKE CCCCCCCCCCCCCCC | 34.50 | 23927012 | |
647 | Phosphorylation | EPAKPSPSRDRKETS CCCCCCCCCCCCCCC | 51.67 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
118 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
297 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
353 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
509 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | PELI1 | Q96FA3 | PMID:19734906 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBP1_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-92; SER-93 ANDSER-645, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-29; SER-30;SER-34; SER-92; SER-93; TYR-270; THR-280 AND SER-463, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND SER-62, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27 AND SER-29, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, AND MASSSPECTROMETRY. |